Global Public Health Solutions

Ellume has developed public health solutions for Influenza, and in partnership with QIAGEN®, Latent Tuberculosis and COVID-19.

Alt Text

COVID-19 QIAreach™ Antigen and Antibody Tests

In partnership with QIAGEN®, Ellume has accelerated the development of two rapid, reliable COVID-19 tests to support the global response to the coronavirus pandemic.

The QIAreach™ Anti-SARS-CoV-2 Antigen Test detects SARS-CoV-2 antigens in people with active infections. The QIAreach™ Anti-SARS-CoV-2 Total Test, is a high-performance serological test which detects antibodies in people who have been exposed to SARS-CoV-2.

Alt Text


We are bringing the next generation of Latent Tuberculosis Infection diagnostics to those who need it most.

In partnership with QIAGEN®, we are advancing the way tuberculosis is diagnosed. Combining our technology with Qiagen’s market leading test, QuantiFERON®, we are taking testing out of the laboratory and into the community.


We have created a highly accurate digital test, which enables a user to detect influenza in 12 minutes. The Ellume Pandemic Influenza Self-test connects to a user’s smartphone and provides simple, step-by-step, on-screen instructions through the test’s app. The app also allows direct access to clinical advice and treatment.

We are working closely with relevant health authorities to connect into aggregated data in real-time, allowing for immediate response during pandemic outbreaks.


* indicates required